EVGN - Evogene Ltd.

1.11
0   0%

Share volume: 69,329
Last Updated: 04-25-2025
Chemicals/Agriculture Chemicals: -0.02%

PREVIOUS CLOSE
CHG
CHG%
$1.11
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
6%
Profitability 0%
Dept financing 7%
Liquidity 50%
Performance 0%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
1.83%
1 Month
-15.27%
3 Months
-27.92%
6 Months
-53.36%
1 Year
70.72%
2 Year
89.45%
Key data
Stock price
$1.11
P/E Ratio 
0.00
DAY RANGE
$1.09 - $1.14
EPS 
-$0.76
52 WEEK RANGE
$0.51 - $5.70
52 WEEK CHANGE
$70.72
MARKET CAP 
16.642 M
YIELD 
N/A
SHARES OUTSTANDING 
5.058 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-22-2025
BETA 
0.93
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$4,340,835
AVERAGE 30 VOLUME 
$1,157,993
Company detail
CEO: Ofer Haviv
Region: US
Website: evogene.com
Employees: 140
IPO year: 2008
Issue type: Common Stock
Market: XNAS
Industry: Chemicals/Agriculture Chemicals
Sector: Manufacturing

Evogene Ltd. focuses on product discovery and development in multiple life-science based industries, including human health and agriculture. It operates through three segments: Agriculture, Human Health, and Industrial Applications. The company has strategic collaborations and licensing agreements with agricultural companies, such as BASF SE, Corteva, and Bayer.

Recent news
loading